In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reimbursement In Brief

This article was originally published in The Gray Sheet

Executive Summary

OIG recommends that CMS lower lab-test payment rates and consider instituting copayments. Imaging groups urge Medicare agency to halt charge compression. More reimbursement briefs.

You may also be interested in...



Lab Tests Face Revaluation, Cuts Under New CMS Proposals

CMS is proposing a comprehensive review process to ensure test payments account for changes in technology. The effort would likely lead to pay reductions in many instances to address new efficiencies in the lab. In addition, double-digit cuts in lab payments are proposed in the agency’s 2014 physician fee schedule draft.

Device Firms Oppose New Imaging Cost Centers For 2014 Medicare Payments

Industry supports CMS’ decision to use specific cost-report lines for implantable devices and cardiac catheterizations, but remains opposed to the proposed cost centers for advanced imaging services.

Reimbursement In Brief

Round two DMEPOS competitive bidding launched July 1 despite efforts by durable medical equipment makers and suppliers to delay it. OIG reports to CMS on continuous positive airway pressure supplies and therapeutic shoes. More reimbursement news.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel